During the pandemic, our client, a global pharmaceutical leader, needed to optimise its COVID-19 vaccine production and delivery processes. Our client had to rapidly implement business applications in order to increase production efficiency.
On the one hand, you can use the experience gained when the pandemic destabilized the market, but on the other – significant flexibility is necessary, as the situation keeps dynamically changing, what with new sanctions being imposed on Russia and Belarus all the time. And information technology has conveniently made it possible to greatly improve the effectiveness of managing operational risks.
In response to an unprecedented global pandemic, our client – one of the pharma industry leaders- set out to develop, test, mass produce and organize the global distribution of a COVID-19 vaccine.
Availability of ICUs is one of the key factors to keep the death toll as low as possible. ICU-M has been one of the reasons Germany has been managing the pandemic relatively well, keeping the number of deaths per 1M population at the low end compared with other EU states.
To get the full picture of the global market situation, companies use various sources of data. But to effectively control and steer business activity at all levels on global scale they need a centralized and trustworthy data source.
Our solutions cover all aspects of customer and sales transactions processing for life science industry companies carrying out their sales activity on many markets in cooperation with wholesalers, distributors and retailers.
Introducing rigorous quality assurance and management tools into data integration to enable the fastest possible resumption of a production plant's functioning shut down due to issues with ERP system implementation.
Scientists are working on new ways to develop vaccines, with the so-called reverse vaccinology (or Vaccinology 3.0) being one of the main trends. This method of vaccine development is fast, but it requires screening the entire pathogen genome. It's a world of huge volumes of data.
With COVID-19 looming, mindful shopping has become a thing. Consumers are more aware of the way they spend their money; they are more open to switching from products they usually buy to cheaper ones. They also do more research before they make the final purchase decision.
The Silicon Review features Leszek Rabiega's (CEO of C&F) article: "Transform your business and innovate with C&F’s explicitly built product portfolio to help you make data-driven decisions".
The current pandemic should become an impulse to prepare for future times of unpredictability. It could be an opportunity if companies consciously work with data and build a solid foundation for decision making. But it could also be a threat if data management is based on solutions that are poorly adjusted to the business model.
RegalixTV published an interview that Piotr Rudnicki gave to Justyna Sidor, a representative of the global business TV network RegalixTV.